With its rich natural resources and biodiverse landscape, the State of Bolivia offers enormous business opportunities for foreign medicinal product and medical device manufacturers. For registrations and market approvals, manufacturers are obliged to obtain authorizations from the Unidad de Medicamentos y Tecnologia en Salud (the Unit of Drugs and Health Technology or UNIMED), a division of Ministry of Health. However, navigating through challenging Regulatory regime in the region might affect manufacturers’ compliance efforts.

Freyr with a specialized Regulatory Affairs consulting support for the Bolivian market, assists manufacturers to decode the local Regulatory requirements and align with them in shorter turnaround times. Freyr’s Regulatory services in Bolivia span across:

  • Medical Devices
  • Drugs
  • Biotech

Freyr Capabilities

  • Strategic Regulatory Consulting
  • Regulatory Affairs & Regulatory intelligence
  • Registration pathways and license management services
  • New Registrations and Renewals

Freyr Advantages

  • Strategic and well-versed local regulatory knowledgebase
  • Regulatory team with proven global RA expertise
  • Proactive and Collaborative approach
  • Quick turnarounds and faster time-to-market
  • Keeping abreast with region-specific legislation and Regulatory guidelines